NASDAQ:ESPR
Esperion Therapeutics Stock News
$2.36
-0.230 (-8.88%)
At Close: May 17, 2024
Nuveen Asset Management LLC Lowers Stock Holdings in Esperion Therapeutics Inc (NASDAQ:ESPR)
09:50am, Saturday, 18'th Apr 2020
Nuveen Asset Management LLC trimmed its stake in Esperion Therapeutics Inc (NASDAQ:ESPR) by 43.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchang
Bailard Inc. Has $2.94 Million Stock Holdings in Esperion Therapeutics Inc (NASDAQ:ESPR)
09:44am, Friday, 17'th Apr 2020
Bailard Inc. grew its holdings in Esperion Therapeutics Inc (NASDAQ:ESPR) by 393.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC).
Northland Capital Markets Maintains Market Perform on Esperion Therapeutics, Lowers Price Target to $42
04:57pm, Thursday, 16'th Apr 2020Esperion price target lowered to $42 from $60 at Northland ESPR
01:21pm, Thursday, 16'th Apr 2020
Esperion price target lowered to $42 from $60 at Northland Northland ESPR
Northland Securities Keeps a Hold Rating on Esperion (ESPR)
11:06am, Thursday, 16'th Apr 2020
Northland Securities analyst Carl Byrnes maintained a Hold rating on Esperion (ESPR) today and set a price target of $42.00. The company's shares closed
Northland Securities Keeps a Hold Rating on Esperion (ESPR)
11:06am, Thursday, 16'th Apr 2020
Northland Securities analyst
Carl Byrnes
maintained a
Hold
rating on Esperion (
ESPR
–
Research Report
) today and set a price target of
$42.00
. The company’s shares closed last Wednesday at $34.
Esperion management to meet virtually with JMP Securities ESPR
03:41pm, Wednesday, 15'th Apr 2020
Esperion management to meet virtually with JMP Securities ESPR
Should You Buy These 4 Biotech Stocks With Recent Drug Approvals?
10:45am, Wednesday, 15'th Apr 2020
These companies scored recent drug approvals. It's worth looking into their stocks to see if they're a buy now.
Geode Capital Management LLC Sells 7,099 Shares of Esperion Therapeutics Inc (NASDAQ:ESPR)
10:20am, Wednesday, 15'th Apr 2020
Geode Capital Management LLC trimmed its holdings in shares of Esperion Therapeutics Inc (NASDAQ:ESPR) by 2.0% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 3
Stocks To Watch: Big Banks And Vaccine Players In The Spotlight
12:35pm, Saturday, 11'th Apr 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
Biotech Roundup: GSK’s Ante, Shakeup at Sage, Telehealth’s Rise & More
01:12pm, Friday, 10'th Apr 2020
The COVID-19 pandemic has stopped enrollment in many clinical trials and postponed the start of others but there is still life in the life sciences
3,926 Shares in Esperion Therapeutics Inc (NASDAQ:ESPR) Acquired by Janus Henderson Group PLC
10:34am, Friday, 10'th Apr 2020
Janus Henderson Group PLC acquired a new stake in Esperion Therapeutics Inc (NASDAQ:ESPR) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Com
Tilray (TLRY) in Focus: Stock Moves 9.6% Higher
01:47pm, Thursday, 09'th Apr 2020
Tilray (TLRY) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.
Tilray (TLRY) in Focus: Stock Moves 9.6% Higher
01:47pm, Thursday, 09'th Apr 2020
Tilray (TLRY) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.
Esperion to Participate in Fireside Chat at the 19th Annual Needham Virtual Healthcare Conference
12:00pm, Thursday, 09'th Apr 2020
Esperion (ESPR) today announced that president and chief executive officer, Tim M. Mayleben, will participate in an analyst-led fireside chat at the 19th Annual Needham Virtual Healthcare Conference o
